| UniProt ID | M2OM_HUMAN | |
|---|---|---|
| UniProt AC | Q02978 | |
| Protein Name | Mitochondrial 2-oxoglutarate/malate carrier protein | |
| Gene Name | SLC25A11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 314 | |
| Subcellular Localization |
Mitochondrion inner membrane Multi-pass membrane protein . |
|
| Protein Description | Catalyzes the transport of 2-oxoglutarate across the inner mitochondrial membrane in an electroneutral exchange for malate or other dicarboxylic acids, and plays an important role in several metabolic processes, including the malate-aspartate shuttle, the oxoglutarate/isocitrate shuttle, in gluconeogenesis from lactate, and in nitrogen metabolism (By similarity). Maintains mitochondrial fusion and fission events, and the organization and morphology of cristae. [PubMed: 21448454 Involved in the regulation of apoptosis (By similarity] | |
| Protein Sequence | MAATASAGAGGIDGKPRTSPKSVKFLFGGLAGMGATVFVQPLDLVKNRMQLSGEGAKTREYKTSFHALTSILKAEGLRGIYTGLSAGLLRQATYTTTRLGIYTVLFERLTGADGTPPGFLLKAVIGMTAGATGAFVGTPAEVALIRMTADGRLPADQRRGYKNVFNALIRITREEGVLTLWRGCIPTMARAVVVNAAQLASYSQSKQFLLDSGYFSDNILCHFCASMISGLVTTAASMPVDIAKTRIQNMRMIDGKPEYKNGLDVLFKVVRYEGFFSLWKGFTPYYARLGPHTVLTFIFLEQMNKAYKRLFLSG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAATASAGA ------CCCCCCCCC | 17.33 | 19413330 | |
| 4 | Phosphorylation | ----MAATASAGAGG ----CCCCCCCCCCC | 16.17 | 25850435 | |
| 6 | Phosphorylation | --MAATASAGAGGID --CCCCCCCCCCCCC | 23.92 | 29255136 | |
| 15 | Ubiquitination | GAGGIDGKPRTSPKS CCCCCCCCCCCCHHH | 27.81 | - | |
| 15 | Acetylation | GAGGIDGKPRTSPKS CCCCCCCCCCCCHHH | 27.81 | 21339330 | |
| 18 (in isoform 2) | Phosphorylation | - | 58.89 | 25056879 | |
| 18 | Phosphorylation | GIDGKPRTSPKSVKF CCCCCCCCCHHHHHH | 58.89 | 22199227 | |
| 19 (in isoform 2) | Phosphorylation | - | 31.45 | 25056879 | |
| 19 | Phosphorylation | IDGKPRTSPKSVKFL CCCCCCCCHHHHHHH | 31.45 | 22199227 | |
| 22 | Phosphorylation | KPRTSPKSVKFLFGG CCCCCHHHHHHHHCC | 33.64 | - | |
| 33 | Sulfoxidation | LFGGLAGMGATVFVQ HHCCCCCCCCEEEEE | 2.48 | 28183972 | |
| 34 (in isoform 2) | Phosphorylation | - | 19.71 | - | |
| 34 | Phosphorylation | FGGLAGMGATVFVQP HCCCCCCCCEEEEEE | 19.71 | - | |
| 52 | Phosphorylation | VKNRMQLSGEGAKTR HHHHHHHCCCCCCCH | 20.22 | 21406692 | |
| 57 | 2-Hydroxyisobutyrylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | - | |
| 57 | Ubiquitination | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | 21890473 | |
| 57 | Succinylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | 21890473 | |
| 57 | Succinylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | - | |
| 62 | Ubiquitination | GAKTREYKTSFHALT CCCCHHHHHHHHHHH | 32.70 | 21890473 | |
| 63 | Phosphorylation | AKTREYKTSFHALTS CCCHHHHHHHHHHHH | 35.41 | 27050516 | |
| 64 | Phosphorylation | KTREYKTSFHALTSI CCHHHHHHHHHHHHH | 15.75 | 27050516 | |
| 69 | Phosphorylation | KTSFHALTSILKAEG HHHHHHHHHHHHHCC | 17.95 | 27050516 | |
| 70 | Phosphorylation | TSFHALTSILKAEGL HHHHHHHHHHHHCCC | 27.12 | 27050516 | |
| 73 | Ubiquitination | HALTSILKAEGLRGI HHHHHHHHHCCCCHH | 42.60 | 73 | |
| 73 | Acetylation | HALTSILKAEGLRGI HHHHHHHHHCCCCHH | 42.60 | 19608861 | |
| 78 | Methylation | ILKAEGLRGIYTGLS HHHHCCCCHHHHHHC | 40.08 | 115917065 | |
| 95 | Phosphorylation | LLRQATYTTTRLGIY HHHHCCCCCHHHCHH | 19.82 | 26437602 | |
| 102 | Phosphorylation | TTTRLGIYTVLFERL CCHHHCHHHHHHHHH | 6.76 | 25147952 | |
| 103 | Phosphorylation | TTRLGIYTVLFERLT CHHHCHHHHHHHHHH | 14.60 | 22673903 | |
| 115 | Phosphorylation | RLTGADGTPPGFLLK HHHCCCCCCCCHHHH | 27.19 | 24641631 | |
| 127 | Sulfoxidation | LLKAVIGMTAGATGA HHHHHHCCCCCCCCC | 1.27 | 28183972 | |
| 161 | Phosphorylation | PADQRRGYKNVFNAL CHHHHHCHHHHHHHH | 9.51 | - | |
| 162 | Ubiquitination | ADQRRGYKNVFNALI HHHHHCHHHHHHHHH | 49.84 | 21890473 | |
| 201 | Phosphorylation | VNAAQLASYSQSKQF HCHHHHHHHHCCCCH | 33.63 | 28152594 | |
| 202 | Phosphorylation | NAAQLASYSQSKQFL CHHHHHHHHCCCCHH | 12.72 | 28152594 | |
| 203 | Phosphorylation | AAQLASYSQSKQFLL HHHHHHHHCCCCHHH | 26.03 | 28152594 | |
| 205 | Phosphorylation | QLASYSQSKQFLLDS HHHHHHCCCCHHHHC | 23.60 | 28152594 | |
| 256 | Succinylation | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | 23954790 | |
| 256 | Acetylation | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | - | |
| 256 | Ubiquitination | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | - | |
| 303 | Sulfoxidation | TFIFLEQMNKAYKRL HHHHHHHHHHHHHHH | 3.97 | 28183972 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of M2OM_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of M2OM_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M2OM_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| COPA_HUMAN | COPA | physical | 16169070 | |
| M2OM_HUMAN | SLC25A11 | physical | 8597574 | |
| POTEI_HUMAN | POTEI | physical | 26186194 | |
| ACTBL_HUMAN | ACTBL2 | physical | 26186194 | |
| YTHD1_HUMAN | YTHDF1 | physical | 26186194 | |
| FYN_HUMAN | FYN | physical | 26186194 | |
| YES_HUMAN | YES1 | physical | 26186194 | |
| PPR1A_HUMAN | PPP1R1A | physical | 26186194 | |
| REN3B_HUMAN | UPF3B | physical | 26186194 | |
| SMAP2_HUMAN | SMAP2 | physical | 26186194 | |
| KPCA_HUMAN | PRKCA | physical | 26186194 | |
| ZN703_HUMAN | ZNF703 | physical | 26186194 | |
| WIPI4_HUMAN | WDR45 | physical | 26186194 | |
| PRG2_HUMAN | PRG2 | physical | 26186194 | |
| VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
| VDAC2_HUMAN | VDAC2 | physical | 26344197 | |
| VDAC3_HUMAN | VDAC3 | physical | 26344197 | |
| POTEI_HUMAN | POTEI | physical | 28514442 | |
| PPR1A_HUMAN | PPP1R1A | physical | 28514442 | |
| SMAP2_HUMAN | SMAP2 | physical | 28514442 | |
| ACTBL_HUMAN | ACTBL2 | physical | 28514442 | |
| YTHD1_HUMAN | YTHDF1 | physical | 28514442 | |
| PRG2_HUMAN | PRG2 | physical | 28514442 | |
| WIPI4_HUMAN | WDR45 | physical | 28514442 | |
| ACTB_HUMAN | ACTB | physical | 28514442 | |
| YES_HUMAN | YES1 | physical | 28514442 | |
| ZN703_HUMAN | ZNF703 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73, AND MASS SPECTROMETRY. | |